Compare BSM & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSM | ITGR |
|---|---|---|
| Founded | 1876 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | 2015 | 2000 |
| Metric | BSM | ITGR |
|---|---|---|
| Price | $14.64 | $86.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $13.00 | ★ $86.67 |
| AVG Volume (30 Days) | 332.1K | ★ 503.1K |
| Earning Date | 02-23-2026 | 02-19-2026 |
| Dividend Yield | ★ 8.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.16 | ★ 2.42 |
| Revenue | $412,814,000.00 | ★ $1,831,074,000.00 |
| Revenue This Year | $1.33 | $9.58 |
| Revenue Next Year | $8.59 | N/A |
| P/E Ratio | ★ $12.63 | $35.44 |
| Revenue Growth | N/A | ★ 9.54 |
| 52 Week Low | $11.78 | $62.00 |
| 52 Week High | $15.52 | $146.36 |
| Indicator | BSM | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 66.98 | 67.91 |
| Support Level | $13.88 | $84.41 |
| Resistance Level | $14.36 | $87.69 |
| Average True Range (ATR) | 0.27 | 2.39 |
| MACD | 0.11 | 0.23 |
| Stochastic Oscillator | 88.75 | 88.98 |
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.